Evidence map›Paper›PMID 41272739›Full record

ArticleAnnals of general psychiatry2025

Smoking status and the onset of suicidal ideation among adults in Japan during the COVID-19 pandemic.

Andrew Stickley, Aya Shirama, Tomiki Sumiyoshi

Abstract read
In one paragraph

Article in Annals of general psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew StickleyDepartment of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho Kodaira, Kodaira, Tokyo, 187-8553, Japan.
Aya ShiramaDepartment of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho Kodaira, Kodaira, Tokyo, 187-8553, Japan.
Tomiki SumiyoshiDepartment of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho Kodaira, Kodaira, Tokyo, 187-8553, Japan. sumiyot@ncnp.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs previous research has linked smoking to suicidal behavior, it is possible that smoking may have played a role in suicidality during the COVID-19 pandemic. However, relatively little research has examined this association. To address this gap, the present study examined the relationship between smoking status and the onset of suicidal ideation in Japan during the pandemic.

methodsData were analyzed from 3,164 adults from the Japanese general population who participated in an online survey in early 2023. Information was collected on smoking status and incident suicidal ideation during the COVID-19 pandemic. Logistic regression was conducted to examine associations.

resultsIn a fully adjusted analysis, current smoking was associated with significantly higher odds of the onset of suicidal ideation in the total sample (OR: 2.31, 95%CI: 1.37, 3.90). In a sex-stratified analysis, both former (OR: 4.49, 95%CI: 1.75, 11.50) and current smoking (OR: 6.12, 95%CI: 2.67, 14.01) were associated with the onset of suicidal ideation in men, whereas no such association was observed in women.

conclusionSmoking was associated with the onset of suicidal ideation among adults in Japan during the COVID-19 pandemic, with the association observed in men but not women.

Indexed as

CigarettesCoronavirus pandemicJapanSuicideTobacco

Identifiers

PMID41272739
PMCPMC12639973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.